Momir Bosiljcic

Title: Innovations of Momir Bosiljcic in Immunotherapy

Introduction

Momir Bosiljcic is a notable inventor based in Burnaby, Canada. He has made significant contributions to the field of immunotherapy, particularly through his innovative approaches to triggering innate immune responses.

Latest Patents

Bosiljcic holds a patent for a groundbreaking invention titled "Therapeutically triggering an innate immune response in a target tissue." This invention provides therapeutic compositions that present an artificial repertoire of mammalian pattern recognition receptor (PRR) agonists. The unique aspect of this invention is that the pattern of PRR agonists recapitulates a distinct portion of a PRR agonist signature of a mammalian pathogen. The artificial repertoire of PRR agonists can be formulated together in a therapeutic vehicle, which is designed to deliver the PRR agonists to the target tissue, thereby modulating an immune response.

Career Highlights

Throughout his career, Bosiljcic has been associated with Qu Biologics Inc., where he has been able to apply his innovative ideas in a practical setting. His work has focused on enhancing the effectiveness of immune responses, which is crucial for developing new therapeutic strategies.

Collaborations

Bosiljcic has collaborated with notable colleagues, including Harold David Gunn and David W Mullins. These collaborations have likely contributed to the advancement of his research and the successful development of his patent.

Conclusion

Momir Bosiljcic's work in immunotherapy exemplifies the impact of innovative thinking in medicine. His patent for triggering innate immune responses showcases the potential for new therapeutic approaches in treating diseases.